TriangleNCT03096782 · OUTCOME
Time to Engraftment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 12 months after transplant
What was measured
Number of days from transplant when participants achieved engraftment measure by ANC of 0.5 for three consecutive days.
Groups in this outcome
Chemotherapy Plus Cord Blood Transplant
GVHD PROPHYLAXIS: All patients receive mycofenolate mofetil IV over 2 hours or PO BID on days -3 with a taper beginning on day 100 in the absence of GVHD, tacrolimus IV or PO starting on day -2 for 6 months in the absence of GVHD, and filgrastim-sndz SC QD starting on day 0 until white blood count begins to recover. Anti-Thymocyte Globulin: Given IV Busulfan: Given IV Clofarabine: Given IV Filgrastim-sndz: Given SC Fludarabine: Given IV Mycophenolate Mofetil: Given IV or PO Rituximab: Given IV Tacrolimus: Given IV Total-Body Irradiation: Undergo total body irradiation Umbilical Cord Blood Transplantation: Undergo cord blood transplant
| Group | Source count |
|---|---|
| Chemotherapy Plus Cord Blood Transplant | 6 |
Reported measurements
Twenty Two Days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy Plus Cord Blood Transplant | 2 | Not reported | Not reported | Not reported | Not reported |
Twenty Nine Days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy Plus Cord Blood Transplant | 1 | Not reported | Not reported | Not reported | Not reported |
Thirty Days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy Plus Cord Blood Transplant | 1 | Not reported | Not reported | Not reported | Not reported |
Nine Days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy Plus Cord Blood Transplant | 1 | Not reported | Not reported | Not reported | Not reported |
Thirty Two Days
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Chemotherapy Plus Cord Blood Transplant | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- title
- Twenty Two Days
- categories
- measurements
- group Id
- OG000
- value
- 1
- title
- Twenty Nine Days
- categories
- measurements
- group Id
- OG000
- value
- 1
- title
- Thirty Days
- categories
- measurements
- group Id
- OG000
- value
- 1
- title
- Nine Days
- categories
- measurements
- group Id
- OG000
- value
- 1
- title
- Thirty Two Days
- denoms
- counts
- group Id
- OG000
- value
- 6
- units
- Participants
- description
- Number of days from transplant when participants achieved engraftment measure by ANC of 0.5 for three consecutive days.
- groups
- description
- GVHD PROPHYLAXIS: All patients receive mycofenolate mofetil IV over 2 hours or PO BID on days -3 with a taper beginning on day 100 in the absence of GVHD, tacrolimus IV or PO starting on day -2 for 6 months in the absence of GVHD, and filgrastim-sndz SC QD starting on day 0 until white blood count begins to recover. Anti-Thymocyte Globulin: Given IV Busulfan: Given IV Clofarabine: Given IV Filgrastim-sndz: Given SC Fludarabine: Given IV Mycophenolate Mofetil: Given IV or PO Rituximab: Given IV Tacrolimus: Given IV Total-Body Irradiation: Undergo total body irradiation Umbilical Cord Blood Transplantation: Undergo cord blood transplant
- id
- OG000
- title
- Chemotherapy Plus Cord Blood Transplant
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Up to 12 months after transplant
- title
- Time to Engraftment
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice